# REDUCE LAP-HF TRIAL II

> **NCT03088033** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Corvia Medical** · enrollment: 608 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** IASD System II implant
- **OTHER:** intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)

## Key facts

- **NCT ID:** NCT03088033
- **Lead sponsor:** Corvia Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-06-01
- **Primary completion:** 2021-07-29
- **Final completion:** 2026-09
- **Target enrollment:** 608 (ESTIMATED)
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03088033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03088033, "REDUCE LAP-HF TRIAL II". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03088033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
